Correction: Efficacy and Safety of Long-Term Administration of Esomeprazole in Japanese Pediatric Patients Aged 1-14 Years with Chronic Gastric Acid-Related Disease

DOI QR Code

Masaaki Mori (Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University) ;
Yoshiko Nakayama (School of Health Science, Shinshu University School of Medicine) ;
Shigeo Nishimata (Department of Pediatrics and Adolescent Medicine, Tokyo Medical University) ;
Tadafumi Yokoyama (Department of Pediatrics, Kanazawa University) ;
Ryo Matsuoka (Department of Pediatrics, Fuji City General Hospital) ;
Reiko Hatori (Center of Regional Medical Research and Education, Gunma University Hospital) ;
Masaki Shimizu (Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University) ;
Katsuhiro Arai (Division of Gastroenterology, National Center for Child Health and Development) ;
Yuri Etani (Department of Pediatric Gastroenterology, Nutrition and Endocrinology, Osaka Women's and Children's Hospital) ;
Tsuyoshi Sogo (Department of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohama City Tobu Hospital) ;
Tomoko Ishizu (Research and Development, AstraZeneca) ;
Masahiro Nii (Research and Development, AstraZeneca) ;
Ryosuke Nakashima (Research and Development, AstraZeneca) ;
Toshiaki Shimizu (Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine)

This research was funded by AstraZeneca.